For example, around 90% of the tumours arising in ENU-treated Apchet-primed mice contained at least one Apc mutation, as did around 60% of tumours from control or Ptennull-primed mice (Fig. 1h and Extended Data Fig. 3g). This evidence concerns the gene APC and neoplasm.